-
CHMP highlights: October 2021
CHMP highlights: October 2021
-
CHMP highlights: October 2021
CHMP highlights: October 2021
EMA’s human medicines committee (CHMP) recommended six medicines for approval at its October 2021 meeting
-
New application for COVID-19 treatment
New application for COVID-19 treatment
-
New application for COVID-19 treatment
New application for COVID-19 treatment
EMA starts a rolling review of Evusheld, a combination of two monoclonal antibodies developed for the prevention of COVID-19 in adults
-
Update on rolling review of COVID-19 vaccines
Update on rolling review of COVID-19 vaccines
-
Update on rolling review of COVID-19 vaccines
Update on rolling review of COVID-19 vaccines
EMA ends the rolling review of CVnCoV, CureVac AG ‘s COVID-19 vaccine, after the company informed the Agency that it was withdrawing from the process.
-
Comirnaty and Spikevax: third doses and boosters
Comirnaty and Spikevax: third doses and boosters
-
Comirnaty and Spikevax: third doses and boosters
Comirnaty and Spikevax: third doses and boosters
EMA’s human medicines committee (CHMP) recommends third doses and boosters for the COVID-19 vaccines Comirnaty (BioNTech/Pfizer) and Spikevax (Moderna)
